v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss from continuing operations $ (4,376,680) $ (2,266,680) $ (17,518,873) $ (7,039,604)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization of intangible assets 563,158 151 94,443 611
Amortization of operating lease right-of-use asset 16,398 18,956 64,388 122,553
Stock-based compensation and service expense 319,819 26,371 1,816,462 521,509
Income (loss) from equity method investment (392,677) (392,677) 846,588
Distribution of earnings from equity method investment     611,888
Amortization of debt issuance costs and debt discount 189,417 283,755 1,136,412 1,291,814
Change in fair market value of derivative liability 1,276,889 114,360 (538,213) (374,365)
Impairment of laboratory equipment     111,033
Debt modification charge     688,794
Loss on extinguishment of debt     9,076,587
Changes in operating assets and liabilities:        
Security deposit 5,473 17,491
Prepaid expense and other assets (37,854) (36,904) (22,299) (106,999)
Accrued liabilities and other payables (796,128) 575,016 1,750,047 (1,205,676)
Accrued liabilities and other payables - related parties     (14,051)
Operating lease obligation (15,398) (18,956) (64,388) (122,553)
NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS (2,860,379) (1,691,135) (4,580,620) (4,668,458)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Payment for equity interest purchase     (100,000)
Cash acquired on acquisition     14,026
Proceeds from sale of equity method investment 280,500 95,000 1,069,000
NET CASH PROVIDED BY INVESTING ACTIVITIES FROM CONTINUING OPERATIONS 280,500 95,000 1,083,026 (100,000)
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from issuance of convertible debt and warrants     3,367,750
Proceeds from issuance of convertible debt     200,000
Payments of convertible debt issuance costs     (282,700)
Repayments of bridge loan (250,000)    
Repayments of convertible debt (200,000) (3,388,222)
Proceeds from issuance of debt 1,164,000    
Payments of debt issuance costs (34,000)    
Advance from pending sale of subsidiary 219,972    
Proceeds received from the February 2026 private offering 3,249,412    
Disbursements for the February 2026 private offering costs (492,600)    
Repayments of loan payable - related party     (400,000)
Proceeds from stock subscription liability     150,000
Advance from pending sale of noncontrolling interest in subsidiary     49,972 2,122,392
Proceeds from issuance of convertible preferred stock     300,000 3,500,000
Payments of convertible preferred stock issuance costs     (10,000)
Proceeds from issuance of bridge loan     300,000
Proceeds from issuance of common stock and warrants     475,500
Payments of offering costs     (64,652)
Proceeds from equity offering     2,857,852
Disbursements for equity offering costs     (138,405)
NET CASH PROVIDED BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS 3,436,812 219,972 1,400,820 7,638,667
Net cash used in operating activities from discontinued operations (231,956) (209,688) (407,434) (289,965)
Net cash used in investing activities from discontinued operations     (35,865)
NET CASH FLOWS USED IN DISCONTINUED OPERATIONS (231,956) (209,688) (443,299) (289,965)
EFFECT OF EXCHANGE RATE ON CASH - CONTINUING OPERATIONS 41,927 231 (9,018) 1,447
NET INCREASE (DECREASE) IN CASH 666,904 (1,585,620) (2,549,091) 2,581,691
CASH - beginning of period 109,091 2,658,182 2,658,182 76,491
CASH - end of period 775,995 1,072,562 109,091 2,658,182
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest 106,025 164,500 916,643 1,088,512
Cash paid for:        
Interest 106,025 164,500 916,643 1,088,512
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Common stock issued for future services 106,381 51,635 8,530
Common stock issued for accrued liabilities 96,600 42,385 42,385 60,000
Receivable related to sale of equity method investment 1,745,000 1,745,000
Related party payable extinguished upon sale of equity method investment 632,916 632,916
Series B Convertible Preferred Stock extinguished related to sale of equity method investment 11,000,000 11,000,000
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock 9,000,000 9,000,000
Stock warrants issued as placement agent fee 294,001    
Warrants issued as convertible note payable finder’s fee     40,900
Warrants issued with convertible note payable recorded as debt discount     438,568
Common stock issued as convertible note payable commitment fee     26,800 320,546
Equity method investment payable paid by a related party     566,667
Reclassification of deferred offering costs     175,136
Settlement of derivative liability 1,281,603 18,853 176,529 2,354
Issuance of common stock upon cashless exercise of stock warrants 127 19 43 4
Issuance of common stock upon cashless exercise of pre-funded stock warrants 35    
Initial ROU asset and lease liability 169,743 127,486 127,486
Conversion of convertible note payable and accrued interest into common stock 551,474 2,244,622
Series C Convertible Preferred Stock converted into common stock 723,000    
Related party gain on deconsolidation of Avalon RT 9 $ 1,861,266    
Deferred financing costs in accrued liabilities     45,000
Legal fees recorded to receivable from sale of equity method investment     50,000
Reclassification of related party loan payable and accrued expenses to advance from related party     500,000
Shares issued for adjustments for 1:15 reverse split     21
Bridge loan issuance costs in accrued liabilities     18,846
Common stock issued as convertible note payable commitment fee included in accrued liabilities     $ 138,000